Low-dose leukocyte interferon-α therapy in dialysed patients with chronic Hepatitis C

Current Medical Research and Opinion

Volumn 14, Issue 3, 1998, Pages 141-144

  Benci, Antonio ^a   Caremani, Marcello ^a   Menchetti, Donatella ^a   Sasdelli, Mauro ^b   Giusti, Pia Bruna ^b  

^a Unita Operativa di Medidna Malat I   (Italy)

^b Unità Operativa di Nefrologia   (Italy)

Author keywords

Chronic hepatitis C; Dialysis; Efficacy; Human leukocyte interferon; Tolerability

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; DIALYSIS; DRUG ACTIVITY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; MALE; RELAPSE; VIREMIA;

EID: 0031666381     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007999809113353     Document Type: Article

References (8)

1. Pol, S. and Legendre, C. (1994). Viral hepatitis in hemodialysis and renal transplantation patients. Néphrologie, 15, 191-195.
2. Umlauft, F., Weiss, G., Urbanek, M., Haun, M., Weyrer, K., Koenig, P., Vogel, W. and Grünewald, K. (1994) Kinetics of HCV-viremia in interferon alpha treated and untreated HCV-infected hemodialysis patients. Hepatology, 20 (Suppl 4, Pt 2), Abstract No. 280.
3. Ellis, M. E., Alfurayh, O., Halim, M. A., Sieck, J. O., Ali, M. A., Bernvil, S. S., Ali, H., Barri, Y., Ayub, A. and al-Fadda, M. (1993). Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha. J. Hepatol., 18, 210-216.
4. Sungur, C., Akpolat, T., Ozcebe, O., Yasavul, U., Turgan, C. and Caglar, S. (1994). Hematologic profile of dialysis patients receiving alpha-interferon and erythropoietin concomitantly. (Letter). Nephron, 67, 449.
5. Fernàndez, J. L., Rendo, P., del Pino, N. and Viola, L. (1997). A double-blind controlled trial of recombinant interferon alfa in hemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the study of HCV infection. J. Viral Hepat., 4, 113-119.
6. Casanovas Taltavull, T., Baliellas, C., Sesé, E., Cervantes, X., Perellò, A., Benasco, C., Andrés E., Gonzàlez, M. T., Gil-Vernet, S., Casanova, A., Casais, L. A. (1995). Chronic HCV infection in HD (hemodialysed) candidates to KT (kidney transplant). Influence of HCV genotypes on response to IFN (interferon). Hepatology, 22 (Suppl 4, Pt 2), Abstract No. 1175.
7. Hirsch, M. S., Tolkoff-Rubin, N. E., Kelly, A. P. and Rubin, R. H. (1983). Pharmacokinetics of human and recombinant leukocyte interferon in patients with chronic renal failure who are undergoing hemodialysis. J. Infed. Dis., 148, 335.
8. Ludwig, J. (1993). The nomenclature of chronic active hepatitis: an obituary. Gastroenterology, 105, 274-278.